B

Brown University Health

Remote behavioral health care platform analytics

ECMO Specialist

Full-Time
$37.57 - $61.45
Mid
Bachelor's, Associate's
Providence, RI, USA
In Person
Medical, Clinical & VeterinaryNursing & Frontline Patient Care

About the job

Requirements
  • An active Rhode Island Respiratory Therapy state license is required.
  • Registration by the National Board for Respiratory Care is required within six months of hire.
  • An Associate's degree in Applied Science in Respiratory Therapy is required; a Bachelor's degree is preferred.
  • One year of critical care experience in respiratory care and mechanical ventilation across all age groups is required.
  • Successful completion of the Rhode Island Hospital Respiratory Care Department ECMO training course is required.
  • Current and active Basic Life Support certification is required; Pediatric Advanced Life Support and Advanced Cardiovascular Life Support certifications are required within six months. Certifications must be from the American Heart Association.
  • Proficiency in advanced respiratory care practices across all age groups is required.
  • Knowledge of the care and administration of blood and blood products is required.
  • The ability to train, orient, and mentor new ECMO staff members is required.
  • A minimum of 80 pump hours per year must be maintained.
  • Participation in ECMO on-call scheduling and routine ECMO competencies and drills, including I-Stat recertification, is required.
Responsibilities
  • Assess patients and initiate, modify, and wean extracorporeal membrane oxygenation (ECMO), also known as extracorporeal life support, for neonatal, pediatric, and adult populations in collaboration with a physician with ECMO expertise.
  • Evaluate patients and perform prescribed clinical procedures and therapy as ordered by a licensed medical provider, working under the general supervision of the ECMO Manager and Respiratory Care department supervisors and managers.
  • Analyze clinical patient data to determine appropriate therapy or intervention and recommend patient care to medical staff.
  • Modify therapy based on patient physiology and response, applying knowledge of indications, contraindications, and the safe and effective use of hospital-approved pharmacological agents and blood products delivered through the ECMO system.
  • Accept verbal orders from physicians, nurse practitioners, and physician assistants when appropriate.
  • Assist physicians with ECMO initiation; assemble and prime the ECMO circuit and evaluate its acid-base status before ECMO begins.
  • Analyze patient data and adjust the ECMO system to maintain prescribed acid-base balance, anticoagulation, circuit pressures, platelets, hematocrit, and temperature parameters.
  • Participate in bedside rounds to review and discuss patient care and recommend treatment methods.
  • Initiate, deliver, and discontinue medications and blood products through the ECMO system; monitor, evaluate, and adjust anticoagulation therapy under physician direction.
  • Coordinate and accompany ECMO patients during intra-hospital and inter-hospital transport, continuously monitoring and assessing patients to maintain safety.
  • Provide care for up to two ECMO patients simultaneously.
  • Provide clinical instruction to healthcare providers on ECMO equipment, procedures, and management; evaluate, maintain, monitor, and troubleshoot ECMO delivery equipment.
  • Maintain a standby ECMO circuit and emergency ECMO equipment at the bedside and ensure their availability and functionality.
  • Participate in departmental orientation and competency training for ECMO and related procedures.
  • When not working as an ECMO Specialist, function as a staff respiratory therapist and assess the clinical appropriateness, efficacy, and patient response to basic and medically complex respiratory care procedures for cardiopulmonary conditions.
  • Provide complex intensive respiratory care and mechanical ventilation to patients of all ages in acute intensive care areas.
  • Provide services to the Code Response Team and Rapid Response/Fast Team, and support high-risk transport of ECMO patients to and from outlying facilities (LifePact).
  • Provide care involving high-frequency ventilation, bronchoscopy assistance, percutaneous tracheostomy procedures, nitric oxide delivery, heliox, and other medical gas delivery.
  • Participate in approved Institutional Review Board medical research projects.
  • Clean and restock the pump and equipment cart after ECMO discontinuation, following hospital infection-control and biohazard-waste policies for circuit components.
  • Assemble and assess all components of the SCUF-to-ECMO interface and monitor and evaluate its operation.
  • Participate in departmental quality improvement activities, including documenting variances during ECMO administration.
  • Attend ECMO staff meetings for case peer review and in-service education, and provide in-service education to healthcare professionals.
  • Perform periodic practice primes, wet drills, and simulation activities.
  • Record pertinent data on flow sheets and in the electronic medical record and write shift notes.
  • Safeguard patient privacy and the confidentiality of health information.
  • Maintain and update clinical knowledge and skills in accordance with current ECMO and respiratory care education practices, and complete mandatory departmental and system training and competencies.
  • Identify learning needs and goals and develop a plan to meet them.
  • Contribute to relevant committees, professional meetings, continuing education, and formal academic programs.
  • Serve as an alternate supervisor and/or ECMO backup when assigned.
Desired Qualifications
  • A Bachelor's degree in Respiratory Therapy is preferred.

About the company

B

Brown University Health

View

Memoir Health provides a behavioral healthcare platform that enables home-based care for behavioral health and substance use issues. It helps health systems remotely manage patients with tools like remote patient monitoring, scheduling, virtual care, and outcomes management, powered by a data analytics engine that highlights cost-saving opportunities and supports automated workflows and one-click referrals. The platform differentiates itself by automating care journeys and delivering integrated, outcomes-focused care within managed care and other healthcare networks, reducing administrative workload for clinicians. Its goal is to make care more proactive, accessible, and coordinated from patients’ homes, improving outcomes while lowering costs, and Memoir Health was later acquired by Lumeo Health in 2020.

Company Size

1-10

Company Stage

Seed

Total Funding

$7.5M

Headquarters

New York City, New York

Founded

2018

Get referred to Brown University Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • A $37 million Starr Foundation alliance launched September 2026 for aging research.
  • Brown Health targets 30,000 new primary-care patients and 27 hires over three years.
  • Primary-care waitlists fell from 14,000 to 4,800, showing access improvements.

What critics are saying

  • UnitedHealthcare Medicare Advantage cutoffs hit 1,900 members in July 2026, hurting referrals.
  • A Massachusetts data breach investigation remains unresolved, exposing patient trust and regulatory risk.
  • Fiscal 2025 margin was 0.9%; weak reimbursement can trigger another existential liquidity squeeze.

What makes Brown University Health unique

  • Brown University Health unites Lifespan hospitals with Brown University academic medicine since 2025.
  • Its 2025 Brown Physicians merger added 500-plus physicians and 1,500-plus providers.
  • Epic, Workday, and Brown-aligned research integration create a larger operating platform.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Retirement Plan
  • Flexible Work Hours
  • Remote Work Options
  • Paid Vacation
  • Paid Holidays
  • Paid Sick Leave
  • Productivity Bonus
  • Stock Options
  • Company Equity

Company News

Providence Business News
Apr 25th, 2023
Miriam Hospital’s palliative care program is first in R.I. and one of few in U.S.

LIFESPAN CORP. and HopeHealth launched the state’s first palliative care program in the emergency department of The Miriam Hospital.

Providence Business News
Jan 4th, 2023
Markell named New CFO of Lifespan Corp.

PETER K. MARKELL was named Lifespan Corp. ’s new chief financial officer and executive vice president, starting Jan. 30.

Providence Business News
Dec 26th, 2022
Pareek appointed chief of urology for Lifespan hospitals

PROVIDENCE – Lifespan Corp. has appointed Dr. Gyan Pareek as chief of urology in the department of surgery at Lifespan hospitals and president of Brown Urology Inc.

Providence Business News
Dec 15th, 2022
Lifespan Cancer Institute launches career program for young people of color

PROVIDENCE – The Lifespan Cancer Institute is launching a new program to train high school students of color for a career in cancer research and medicine.

Business Wire
Dec 15th, 2022
Trisalus Life Sciences Highlights Pressure-Enabled Regional Immuno-Oncology™ (Perio™) Clinical Trial Progress And Pre-Clinical Research Developments

DENVER & CHICAGO--(BUSINESS WIRE)--TriSalus Life Sciences®, Inc. (“TriSalus” or the “company”), an oncology company in the process of going public through a business combination transaction (the “Business Combination”) with MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or “MTAC”), today announced that it has expanded the reach of its ongoing Pressure-Enabled Regional Immuno-Oncology™ (“PERIO™-01” and “PERIO™-02”) clinical program.In recent months TriSalus has opened five new PERIO™-01 (NCT04935229) clinical trial sites, at Stanford University Hospitals, University of California Los Angeles, University of Colorado’s Anschutz Medical Campus, University of Washington Medical Center and University of Miami’s Sylvester Comprehensive Cancer Center, in addition to five previously activated sites. The PERIO™-01 trial is studying an investigational drug, SD-101, delivered intravascularly by the TriNav® Infusion System (“TriNav®”) using the company’s proprietary Pressure-Enabled Drug Delivery™ (“PEDD™”) method of administration. The study is evaluating whether this platform approach with SD-101 and PEDD™ can improve the performance of systemic checkpoint inhibitors in treating patients with uveal melanoma with liver metastases. In addition to these U.S. sites, TriSalus anticipates opening future PERIO™-01 clinical trial sites in the United Kingdom, Europe, and Canada.In parallel, TriSalus opened PERIO™-02 (NCT05220722) trial sites at Columbia University and University of Colorado Denver, along with Rhode Island Hospital – which was announced last month as part of an expanded research collaboration with Lifespan Health System